About
Neuropsychiatry Therapies
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
295
By Phase
PHASE2: 3
By Status
COMPLETED: 2ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06340958Lead Sponsor
A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive Disorder
PHASE2Active, not recruiting
90 participants
Started: Mar 18, 2024 · Completed: Jan 10, 2026
NCT06262607Lead Sponsor
A Study of CLE-400 (Topical Gel) for the Treatment of Chronic Pruritus in Adult Subjects With Notalgia Paresthetica
PHASE2Completed
59 participants
Started: Jan 29, 2024 · Completed: Nov 19, 2024
NCT04103892Lead Sponsor
A Study of CLE-100 (Oral Esketamine) in Addition to Standard Antidepressant Drug for Major Depressive Disorder - CLEO Study
PHASE2Completed
146 participants
Started: Sep 5, 2019 · Completed: Oct 5, 2022
Locations (1)
Headquarters
Petach Tikva, Israel
Map
Loading map...